跳至主要内容
临床试验/NCT02665520
NCT02665520Unknown2 期

Phase 1 Study of the Use of Autologous Penile Stem Cells in Men With Erectile Dysfunction

Elaj medical centers3 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
30
试验地点
3
主要终点
Adverse Events that occur during or after the procedure to measure safety and tolerability

研究概览

简要总结

Autologous Fat Derived Stem Cell treatment of ED.

To assess safety and primary efficacy of stem cell infusion in refractory ED.

To investigate the success rate and durability of success of using this new therapy in management of moderate and sever cases of erectile dysfunction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male 40 years old and older suffering from moderate to sever erectile dysfunction -

排除标准

  • Inability to give informed consent or attend follow up
  • Severe diabetic neuropathy (to be defined ? Charcot joints, diabetic ulcers?) or other neuropathic disease
  • Viral disease from infectivity viewpoint
  • Major penile fibrosis or severe Peyronie's disease
  • Severe primary large vessel ED (defined as PSV less than 15cm/s after ICI)
  • Severe primary venous leakage ED (defined as EDV more than 10cm/s after ICI)
  • Prior systemic chemotherapy, or radiotherapy to donor or recipient area
  • Not in potentially active sexual relationship
  • Age less than 40 or over 70

结局指标

主要结局

Adverse Events that occur during or after the procedure to measure safety and tolerability

时间窗: 1 year

to assess efficacy and safety of injection of stem autologous stem cells in penis of ED patients

次要结局

未报告次要终点

研究者

发起方
Elaj medical centers
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamad Habous

Dr Mohamad Habous

Elaj medical centers

研究点 (3)

Loading locations...

相似试验

Penile Intracavernosal Stem Cells Therapy for... | 临床试验